A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients
Authors:
Open Access
- 26 March 2019
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-9
Abstract
Objective. This study aimed to screen prognostic gene signature of glioblastoma (GBM) to construct prognostic model.Methods. Based on the GBM information in the Cancer Genome Atlas (TCGA, training set), prognostic genes (Set X) were screened by Cox regression. Then, the optimized prognostic gene signature (Set Y) was further screened by the Cox-Proportional Hazards (Cox-PH). Next, two prognostic models were constructed: model A was based on the Set Y; model B was based on part of the Set X. The samples were divided into low- and high-risk groups according to the median prognosis index (PI). GBM datasets in Gene Expression Ominous (GEO, GSE13041) and Chinese Glioma Genome Atlas (CGGA) were used as the testing datasets to confirm the prognostic models constructed based on TCGA.Results. We identified that the prognostic 14-gene signature was significantly associated with the overall survival (OS) in the TCGA. In model A, patients in high- and low-risk groups showed the significantly different OS (P = 7.47 × 10−9, area under curve (AUC) 0.995) and the prognostic ability were also confirmed in testing sets (P=0.0098 and 0.037). The model B in training set was significant but failed in testing sets.Conclusion. The prognostic model which was constructed based on the prognostic 14-gene signature presented a high predictive ability for GBM. The 14-gene signature may have clinical implications in the subclassification of GBM.Keywords
This publication has 40 references indexed in Scilit:
- Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesisOncoTargets and Therapy, 2013
- The neurobiology of gliomas: from cell biology to the development of therapeutic approachesNature Reviews Neuroscience, 2011
- Dominant Cone-Rod Dystrophy: A Mouse Model Generated by Gene Targeting of the GCAP1/Guca1a GenePLOS ONE, 2011
- INSL3 has tumor‐promoting activity in thyroid cancerInternational Journal of Cancer, 2010
- On the prognostic value of survival models with application to gene expression signaturesStatistics in Medicine, 2010
- L1Penalized Estimation in the Cox Proportional Hazards ModelBiometrical Journal, 2010
- Understanding survival analysis: Kaplan-Meier estimateInternational Journal of Ayurveda Research, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT ActivityJournal of Clinical Oncology, 2008
- Effect of Normalization on Significance Testing for Oligonucleotide MicroarraysJournal of Biopharmaceutical Statistics, 2004